netFormulary NHS
Milton Keynes Formulary
Milton Keynes University Hospital NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes Clinical Commissioning Group
Milton Keynes Community Health Services
 Search
 Formulary Chapter 4: Central nervous system - Full Chapter
04.09.01  Expand sub section  Dopaminergic drugs used in Parkinsons disease
04.09.01  Expand sub section  Dopamine receptor agonists
Apomorphine
View adult BNF View SPC online View childrens BNF
Formulary
Amber SCG
  • APO-go PEN 10mg/ml; 3ml Pen Injector
  • APO-go PFS 5mg/ml; 10ml prefilled syringe
  • APO-go 10mg/ml ampoules; 2ml and 5ml amps

Note:  See Shared Care Guideline here

Shared care prescribing guideline. Apomorphine in Parkinson's disease.

 
Link  Manufacturers guide: APO-go pen
Link  Manufacturers guide: Setting up the APO-go pump
Link  Manufacturers guide: Setting the APO-go infusion flow rate
Link  MHRA: Apomorphine with domperidone - risks of cardiac side effects (April 2016)
   
Cabergoline
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1

 Tablets 1mg, 2mg

 

Notes:

Cabergoline: Please remember to optimize patient's prescription as their doses change; two 1mg tablets are considerably more costly than one 2mg tablet.

 
   
Pergolide
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1

 Tablets 50 micrograms, 250 micrograms, 1mg

 
   
Pramipexole
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
  • Tablets 88 micrograms, 180 micrograms, 350 micrograms, 700 micrograms
  • Modified Release Tablets 260 micrograms, 520 micrograms, 1.05 mg, 1.57 mg, 2.1 mg, 2.62 mg, 3.15 mg
 
   
Ropinirole
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
  • Tablets 1mg, 2mg, 5mg
  • Starter pack (250micrograms, 500micrograms and 1mg tablets)
  • Modified Release Tablets 2mg, 4mg, 8mg
 
   
Rotigotine
(Parkinsons)
View adult BNF View SPC online View childrens BNF
Formulary
Amber 1
  • Transdermal patch 2mg in 24 hours, 4mg in 24 hours, 6mg in 24 hours, 8 mg in 24 hours  
 
   
04.09.01  Expand sub section  Levodopa
04.09.01  Expand sub section  Monoamine-oxidase-B inhibitors
04.09.01  Expand sub section  Catachol-O-methyltransferase inhibitors to top
04.09.01  Expand sub section  Amantadine
 ....
 Non Formulary Items
Bromocriptine
(Parkinsons)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Lisuride

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Routine prescribing within licensed indication  

Amber 1

Specialist recommendation followed by GP initiation and continuation  

Amber 2

Specialist or GP initiation in line with local guideline after 1st line failure followed by GP continuation   

Amber 3

Specialist initiation and stabilisation followed by GP continuation  

Amber SCG

Specialist initiation and stabilisation followed by GP continuation in line with an agreed shared care guideline  

Red

Hospital or specialist prescribing only  

Red Red

These medicines have been evaluated and rejected by MKPAG and are NOT approved for use within MK. They are not recommended for use because of lack of clinical effectiveness, cost effectiveness or safety.  

netFormulary